21 May 2013
Keywords: merck, serono, licenses, ambrx, ms, drug, division
Article | 02 March 2009
Merck Serono, a division of Germany's Merck KGaA, and USA-based Ambrx will collaborate to develop and commercialize the latter's ARX424, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 March 2009
20 May 2013
© 2013 thepharmaletter.com